CN115518085B - 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 - Google Patents
含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 Download PDFInfo
- Publication number
- CN115518085B CN115518085B CN202211221745.1A CN202211221745A CN115518085B CN 115518085 B CN115518085 B CN 115518085B CN 202211221745 A CN202211221745 A CN 202211221745A CN 115518085 B CN115518085 B CN 115518085B
- Authority
- CN
- China
- Prior art keywords
- extract
- dysmenorrhea
- pleurotus tuber
- pleurotus
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 104
- 241000149440 Lentinus tuber-regium Species 0.000 title claims description 28
- 201000010099 disease Diseases 0.000 title abstract description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 32
- 239000008194 pharmaceutical composition Substances 0.000 title description 10
- 206010013935 Dysmenorrhoea Diseases 0.000 claims abstract description 43
- 208000005171 Dysmenorrhea Diseases 0.000 claims abstract description 42
- 238000002360 preparation method Methods 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 14
- 230000002829 reductive effect Effects 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 10
- 229940011871 estrogen Drugs 0.000 claims abstract description 8
- 239000000262 estrogen Substances 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 208000019255 Menstrual disease Diseases 0.000 claims abstract description 7
- 235000007685 Pleurotus columbinus Nutrition 0.000 claims description 31
- 240000001462 Pleurotus ostreatus Species 0.000 claims description 31
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 31
- 235000013402 health food Nutrition 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 12
- 208000037093 Menstruation Disturbances Diseases 0.000 claims description 8
- 206010027339 Menstruation irregular Diseases 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000009098 adjuvant therapy Methods 0.000 claims 1
- 231100000544 menstrual irregularity Toxicity 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000005906 menstruation Effects 0.000 abstract description 9
- 241000222350 Pleurotus Species 0.000 abstract description 8
- 206010030113 Oedema Diseases 0.000 abstract description 6
- 206010016256 fatigue Diseases 0.000 abstract description 4
- 239000006286 aqueous extract Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 30
- 238000000605 extraction Methods 0.000 description 28
- 239000000203 mixture Substances 0.000 description 23
- 230000002175 menstrual effect Effects 0.000 description 19
- 241000569924 Pinanga maculata Species 0.000 description 18
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 239000011782 vitamin Substances 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- 241000282376 Panthera tigris Species 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 230000003821 menstrual periods Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 150000003180 prostaglandins Chemical class 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010034568 Peripheral coldness Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000252132 Pleurotus eryngii Species 0.000 description 3
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 3
- 206010036618 Premenstrual syndrome Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000000730 antalgic agent Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000005168 endometrial cell Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 229940041476 lactose 100 mg Drugs 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- MNIPYSSQXLZQLJ-UHFFFAOYSA-N Biofenac Chemical compound OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl MNIPYSSQXLZQLJ-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000222383 Polyporales Species 0.000 description 1
- 229920001231 Polysaccharide peptide Chemical class 0.000 description 1
- 241000577946 Sarcodon Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 240000000828 Tecoma stans Species 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229960004420 aceclofenac Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000029849 luteinization Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000754 myometrium Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 108010022457 polysaccharide peptide Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
- A23L31/15—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种用于制备药剂的虎掌菇提取物的用途,上述药剂用于预防或治疗选自由痛经、月经不调、月经引起的疲劳感及月经引起的浮肿组成的组中的一种妇科疾病,上述妇科疾病为由雌激素不均衡导致的,为了预防或治疗上述妇科疾病,在痛经开始时服用虎掌菇提取物,上述虎掌菇提取物为虎掌菇子实体的水提取物,虎掌菇提取物的制备方法包括:步骤1),放入水后在45‑60℃下30分钟进行第一次提取;步骤2),在90‑105℃下10分钟进行第二次提取;步骤3),过滤步骤2)的提取物;以及步骤4),对步骤3)中过滤的提取物进行减压浓缩后进行干燥。
Description
技术领域
本发明涉及含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物。
背景技术
随着社会进步,职业女性的数量逐渐增加,但由于西式餐饮和速食食品的摄入、来自事业和家庭的压力以及不合理的减肥等原因,使女性体内的营养和激素不均衡,导致许多女性出现月经不调、痛经、皮肤过敏、失眠、脱发、抑郁、以及身高和胸部发育不良等疾病。
对于这些疾病,大多使用向患者施用人工合成雌激素的激素替代疗法,但长期使用这种疗法可能诱发子宫癌、乳房癌、静脉血栓、胆囊疾病等,因此受到诸多限制。
痛经在育龄妇女中出现的概率高达50%,为常见的妇科疾病之一,初发于初潮后的第一至两年间,在十几岁或二十几岁的女性中属常见症状,但有甚者到四十多岁还在继续,这其中大约10%的人反映每个月有一到三天因疼痛而做不了平时能做的事。
痛经出现于经前数小时或月经即将来临之时,疼痛开始于耻骨上部,持续两到三天,原发性痛经源自子宫肌的过度收缩,这类似于分娩时的分娩痛,会伴有尾骨(骶椎)部位的疼痛,疼痛还会向前蔓延到大腿根部,同时伴有恶心、呕吐、腹泻等症状,偶尔会出现昏迷症状。另外,痛经时的疼痛不同于腹腔炎症带来的疼痛,表现为一种绞痛,虽然可以通过按摩骨盆或活动身体来缓解,但还要依据症状程度进行药物治疗。
据韩国庆熙医疗院韩医院的调查结果,月经时出现腹痛、腰痛和头痛等疼痛症状的女性高达47%,出现食欲不振和消化不良等胃肠障碍的达13%,感到不适的为8%,尤其在632名初高中女学生中,70%出现生理痛,50%疼痛的症状严重,但其中66%的人选择忍耐,28%的人使用镇痛剂解决,90%的人不采取根本性的治疗。
痛经的起因还有很多不明之处,但原发性痛经的绝大部分疼痛由子宫内膜细胞的前列腺素分泌增加引起,在黄体期,由于黄体酮水平低下而脱落的子宫内膜细胞的环氧化酶(COX)的活性增加,分泌前列腺素(PG),尤其是PGF2-α和PGE2,在这些前列腺素的作用下,子宫的紧张度增加,出现大幅度的收缩,这样的收缩会带来缺血性疼痛。
现在还没有能够根治痛经的药剂,但通过给药阿司匹林、布洛芬、扑热息痛等药物抑制前列腺素的生成来缓解疼痛的方法而被广泛使用,不过上述药物可带来耐药性、消化不良、恶心、呕吐、便秘、腹泻、头痛、眩晕、视觉障碍、听觉障碍、困倦、疲劳以及胃肠道出血等副作用。
因此,为开发能够无副作用地缓解痛经的物质的研究正在如火如荼地开展。与此相关地,韩国专利公报第10-2015-005430号公开了含人参子提取物的缓解月经前综合征和痛经的组合物,韩国专利公报第10-1598283号公布了能够通过醋氯芬酸和东莨菪碱缓解或治疗痛经。
另外,数千年前人类就已把蘑菇作为食物和药物广泛地加以利用,蘑菇的代谢产物多醣体及多醣体-肽复合体,含有三萜类化合物(triterpenoid)和蛋白质,对多种生理反应有调节能力,在这一点上有重要的药理价值。
在这些蘑菇中,虎掌菇(Sarcodon Asparatus)为多孔菌目(Aphyllophorales)革菌科(Thelphoraceae)的担子菌类蘑菇,子实体高10cm至20cm,外形呈漏斗状像喇叭花,生有许多小针,菌帽直径为7cm至25cm,高7cm至25cm,表面粗糙,有大鳞片。虎掌菇干燥后能够散发出强烈香气,因此又名香菇。虎掌菇对生物机能调节的效果很高,已知对癌症、脑卒中、心脏病等成人疾病的预防和改善有着良好的效果,虎掌菇的根或外生菌根植于栎树之上,在阔叶林的地面群生或单生,由于目前还不能人工栽培,因此只能依靠自然状态的采摘。
对此,本发明人在开发安全无副作用地缓解或治疗痛经的制剂时,确认虎掌菇提取物能够缓解痛经,能够减少经期、月经量、月经不调以及淤血,还能够鲜亮经血,从而完成了本发明。
发明内容
技术问题
本发明的目的在于提供虎掌菇提取物对妇科疾病的预防或治疗用途。
解决问题的方案
为了达到上述目的,本发明提供一种含有虎掌菇提取物作为有效成分的预防或治疗妇科疾病的药学组合物。
并且,本发明还提供一种含有虎掌菇提取物作为有效成分的用于改善妇科疾病的保健食品。
并且,本发明还提供一种包括向对象给药虎掌菇提取物步骤的用于预防、改善或治疗妇科疾病的方法。
进而,本发明还提供一种虎掌菇提取物的用途,能够用于为预防、改善或治疗妇科疾病的药剂的制备。
本申请的用于制备药剂的虎掌菇提取物的用途,上述药剂用于预防或治疗选自由痛经、月经不调、月经引起的疲劳感及月经引起的浮肿组成的组中的一种妇科疾病,
上述妇科疾病为由雌激素不均衡导致的,
为了预防或治疗上述妇科疾病,在痛经开始时服用虎掌菇提取物,
上述虎掌菇提取物为虎掌菇子实体的水提取物,
虎掌菇提取物的制备方法包括:
步骤1),放入水后在45-60℃下30分钟进行第一次提取;
步骤2),在90-105℃下10分钟进行第二次提取;
步骤3),过滤步骤2)的提取物;以及
步骤4),对步骤3)中过滤的提取物进行减压浓缩后进行干燥。
本申请的用于制备保健食品的虎掌菇提取物的用途,上述保健食品用于改善选自由痛经、月经不调、月经引起的疲劳感及月经引起的浮肿组成的组中的一种妇科疾病,
上述妇科疾病为由雌激素不均衡导致的,
为了改善上述妇科疾病,在痛经开始时服用虎掌菇提取物,
上述虎掌菇提取物为虎掌菇子实体的水提取物,
虎掌菇提取物的制备方法包括:
步骤1),放入水后在45-60℃下30分钟进行第一次提取;
步骤2),在90-105℃下10分钟进行第二次提取;
步骤3),过滤步骤2)的提取物;以及
步骤4),对步骤3)中过滤的提取物进行减压浓缩后进行干燥。
发明的效果
只要服用一次本发明所述的虎掌菇提取物就能够治疗痛经,能够减少经期、月经量、月经不调以及淤血,还能够鲜亮经血,能够有效应用于妇科疾病的预防或治疗。
最佳实施方式
以下详细说明本发明。
本发明提供一种含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物。
上述提取物的制备方法包括:1)向虎掌菇加入提取溶剂来进行第一次提取的步骤;2)对上述步骤1)的第一次提取物进行第二次提取的步骤;3)过滤上述步骤2)的提取物的步骤;以及4)对上述步骤3)中过滤的提取物进行减压浓缩后进行干燥的步骤。
根据上述方法,步骤1)的虎掌菇不受栽培的或是采购的限制,都能够使用,也能够使用上述虎掌菇的子实体或菌丝体部分,在本发明的一实施例中,上述虎掌菇提取物可以为从子实体中提取的。
根据上述方法,步骤1)的提取溶剂可以为水、醇或它们的混合物。上述醇具体地为C1至C4低级醇,更具体地,可以为甲醇或乙醇;在本发明的一实施例中,上述提取溶剂可以为水。提取方法可以为减压高温提取、沸水提取、过滤法、热水提取、浸渍提取、回流提取、冷浸提取、蒸汽提取、常温提取或超声波提取等本领域已知的所有提取方法都能够适用,在本发明的一实施例中,上述提取方法可以为热水提取法,上述提取溶剂的添加量为以虎掌菇干燥重量为基准的30倍至90倍,具体地为40倍至80倍,更具体地为50倍至70倍,在本发明的一实施例中,上述提取溶剂的添加量可以为以虎掌菇干燥重量为基准的60倍。
上述步骤1)的第一次提取的执行温度可以为30℃至100℃,具体地为40℃至80℃,更具体地为45℃至60℃,在本发明的一实施例中,上述第一次提取的执行温度可以为50℃。并且,上述第一次提取的执行时间可以为5分钟至1小时,具体地为15分钟至40分钟,更具体地为25分钟至35分钟,在本发明的一实施例中,上述第一次提取的执行时间可以为30分钟。
上述步骤2)的第二次提取的执行温度可以为50℃至120℃,具体地为70℃至110℃,更具体地为90℃至105℃,在本发明的一实施例中,上述第二次提取的执行温度为100℃。并且,上述第二次提取的执行时间可以为5分钟至30分钟,具体地为5分钟至20分钟,更具体地为5分钟至15分钟,本发明的一实施例中,上述第二次提取的执行时间可以为10分钟。
上述妇科疾病可以为由雌激素不均衡导致的,具体地可以为由雌激素不均衡导致的痛经、月经前综合征、浮肿、月经不调、带下症、淤血、手脚冰冷、腰痛、皮肤过敏、失眠、脱发、抑郁、眩晕、头痛、便秘、腹泻、皮肤潮红、耳鸣及尿频等。
在本发明的具体实施例中,本发明人将水加入通过热风干燥后粉碎的虎掌菇子实体中来制备虎掌菇提取物,使每次都因经期严重痛经而服用镇痛剂的17位十几岁至五十几岁的女性服用该提取物。结果,服用虎掌菇提取物的女性在服用之后,痛经马上消失,在服用一次虎掌菇提取物的当月的经期及月经量减少,并且,经血变得鲜亮,淤血消失(参考表1);而且,在服用一次虎掌菇提取物之后,下个月开始即使不再服用虎掌菇提取物,也只出现轻微的痛经或者消失不见,经量减少,淤血消失,上述效果在经过12个月后仍持续(参考表2至表4)。
因此,上述虎掌菇提取物能够有效用作预防或治疗妇科疾病的治疗用药学组合物。
上述药学组合物中,相对于药学组合物的总重量,可以包含10重量百分比至95重量百分比的本发明所述的虎掌菇提取物作为有效成分。并且,本发明所述的药学组合物还可以含有除上述有效成分外的具有相同或类似功能的一种以上有效成分。
本发明所述的组合物还可以包括通常用于生物制剂的载体、稀释剂、赋形剂或它们的两种以上的组合。在药剂学上可接受的载体,适合于向生物体内传递组合物,则不受特别的限制,可以为记载于Merck Index,13th ed.,Merck&Co.Inc.的化合物、生理盐水、灭菌水、林格氏溶液、缓冲生理盐水、葡萄糖溶液、麦芽糊精溶液、甘油、乙醇或者这些成分中一种以上成分的混合物。此时可以根据需要添加抗氧化剂、缓冲液、制菌剂等其他常规添加剂。
对上述组合物进行制剂化时,使用常规的填充剂、增量剂、结合剂、湿润剂、崩解剂、表面活性剂等稀释剂或赋形剂来制备。
本发明所述的组合物可以制成口服制剂或非口服制剂的剂型。用于口服给药的固体制剂包括片剂、丸剂、散剂、颗粒剂、胶囊剂、锭剂等,这样的固体制剂可以在一种以上的组合物中混合一种以上的赋形剂,比如淀粉、碳酸钙、蔗糖、乳糖以及明胶等来制成。并且,还可以混合硬脂酸镁、滑石粉之类的润滑剂。另外,液体制剂包括悬浮剂、内用液剂、油剂或者糖浆剂等,其中可以包括湿润剂、甜味剂、芳香剂、保存剂之类的赋形剂。
非口服制剂包括灭菌的水溶液、非水性溶剂、悬浮溶剂、油剂等注射剂。
非水性溶剂和悬浮溶剂可以使用聚丙二醇、聚乙二醇、橄榄油之类的植物性油脂以及油酸乙酯之类能够用于注射的酯等。
并且,本发明还提供含有虎掌菇提取物作为有效成分的用于改善妇科疾病的保健食品。
上述提取物的制备方法包括:1)向虎掌菇添加提取溶剂进行第一次提取的步骤;2)对上述步骤1)的第一次提取物进行第二次提取的步骤;3)过滤上述步骤2)的提取物的步骤;以及4)对上述步骤3)中过滤的提取物进行减压浓缩后进行干燥的步骤。
根据上述方法,步骤1)的虎掌菇不受栽培的或采购的限制,都能够使用,也能够使用上述虎掌菇的子实体或菌丝体部分,在本发明的一实施例中,上述虎掌菇提取物可以为从子实体中提取的。
上述提取物可以由水、醇或它们的混合物提取。上述醇具体地为C1至C4低级醇,更具体地,可以为甲醇或乙醇。在本发明的一实施例中,上述提取溶剂可以为水。
上述妇科疾病可以为由雌激素不均衡导致的,具体地可以为由雌激素不均衡导致的痛经、月经前综合征、浮肿、月经不调、带下症、淤血、手脚冰冷、腰痛、皮肤过敏、失眠、脱发、抑郁、眩晕、头痛、便秘、腹泻、皮肤潮红、耳鸣及尿频等。
在本发明的具体实施例中,本发明人将水加入通过热风干燥后粉碎的虎掌菇子实体中来制备虎掌菇提取物,使每次都因经期严重痛经而服用镇痛剂的17位十几岁至五十几岁的女性服用该提取物,结果,服用虎掌菇提取物的女性在服用之后,痛经马上消失,在服用一次虎掌菇提取物的当月的经期及月经量减少,并且,经血变得鲜亮,淤血消失(参考表1);而且,在服用一次虎掌菇提取物之后,下个月开始即使不再服用虎掌菇提取物,也只出现轻微的痛经或者消失不见,经量减少,淤血消失,上述效果在经过12个月后仍持续(参考表2至表4)。
因此,上述虎掌菇提取物能够有效应用于改善妇科疾病。
上述保健食品中添加的作为有效成分的虎掌菇提取物的含量可以根据目的确定,通常上述含量为健康食品的总重量的0.01重量份至90重量份。
并且,上述保健食品的形态和种类不受限制,能够添加上述物质的健康食品的形态可以为片剂、胶囊、粉末、颗粒、液态或者丸等。
本发明所述的健康食品与常规的健康食品一样,能够含有各种香味剂或者天然碳水化合物等追加成分,上述天然碳水化合物可以为葡萄糖、果糖之类的单糖,也可以为麦芽糖、蔗糖之类的多糖,也可以为糊精、环状糊精之类的多聚糖,也可以为木糖醇、山梨醇、赤藓糖醇之类的糖醇,甜味剂可以为索马甜、甜叶菊提取物之类的天然甜味剂、也可以为糖精或阿斯巴甜之类的人工甜味剂。
除此之外,本发明所述的保健食品还可以含有各种营养素、维生素、电解质、风味剂、着色剂、果胶酸及其盐、褐藻酸及其盐、有机酸、保护性果胶增稠剂、pH调节剂、稳定剂、防腐剂、甘油或者醇等。这些成分可以单独或者组合使用,相对于100重量份的本发明的提取物,这些添加剂的比率可以在0.01重量份至0.1重量份的范围内。
并且,本发明还提供包括向对象给药虎掌菇提取物的步骤的用于预防、改善或治疗妇科疾病的治疗方法。
本发明所述的虎掌菇提取物可以具有上述特征,上述对象可以为哺乳动物,具体地可以为人类。
本发明所述的组合物根据目的不同而采用口服给药或者非口服给药,非口服给药能够选择外敷或者腹腔内注射、直肠内注射、皮下注射、静脉注射、肌肉注射、或者胸部注射等注入方式。
本发明所述的组合物以药剂学上的有效剂量来给药,可根据疾病的种类、轻重度、药物的活性、对药物的敏感度、给药时间、给药途径及代谢率、疗程以及同时使用的药物等情况不同而有所不同,本发明所述的组合物能够单独给药或与其他治疗剂联合给药,联合给药时,可依次给药或者同时给药。
但是,为了得到优选的效果,本发明所述的组合物中包含的有效成分的量可以为0.001mg/kg至10000mg/kg,具体可以为0.1g/kg至5g/kg,上述给药可以为一日一次,也可以为一日多次。
进而,本发明还提供一种虎掌菇提取物的用途,用于制备预防、改善或治疗妇科疾病的药剂。
本发明所述的虎掌菇提取物可具有上述特征。
具体实施方式
以下,通过下述实施例对本发明进行详细说明。
但下述实施例只是例示本发明,本发明的内容并不限定于下述实施例。
实施例1:虎掌菇提取物的制备
利用常规方法对从韩国庆尚北道安东野山中采集的虎掌菇的子实体进行热风干燥后粉碎,之后将3g粉碎的虎掌菇放入180ml的水中,而后在50℃加热30分钟,再在100℃加热10分钟,得到了虎掌菇提取物。
实验例1:虎掌菇提取物对痛经的疗效的确认
为评价虎掌菇提取物对痛经的缓解及疗效进行了如下实验。
1-1:实验对象
以每次都因经期严重痛经而服用镇痛剂的17位十几岁至五十几岁的女性为对象,评价了虎掌菇提取物对痛经的缓解效果和疗效。
1-2:服用虎掌菇提取物前后对痛经的疗效的确认
为确认服用虎掌菇提取物前后的变化,选择了每次都因经期严重痛经而服用镇痛剂的女性,使其在痛经开始时服用一次通过上述实施例1的方法制备的提取物160ml,随着服用提取物的变化如下面表1所示。
表1:服用虎掌菇提取物前后对比
如表1所示,在服用虎掌菇提取物后不久,所有女性的痛经都消失了,大部分女性在服用一次虎掌菇提取物的当月的经期及月经量减少,经血变得鲜亮,淤血及月经不调消失(表1)。并且,一部分女性因月经而起的无力感、疲劳感及浮肿减少了。
1-3:服用虎掌菇提取物一次后的疗效的确认
调查了服用虎掌菇提取物一次后经过1个月、2个月、3个月、6个月及12个月后的变化如下面表2至表4所示。
表2痛经持续时间比较
表3月经量比较
表4是否产生淤血比较
如表2至表4所示,在服用一次虎掌菇提取物之后,下个月开始即使不再服用虎掌菇提取物,也只出现轻微的痛经或者消失不见,月经量减少,淤血消失,上述效果在经过12个月后仍持续(表2至表4)。
另外,本发明所述的虎掌菇提取物能够根据目的而制成不同形态的制剂,下述介绍含有本发明所述的虎掌菇提取物作为有效成分的几种制剂化方法,只是例示,本发明不限定于此。
制剂例1:药学制剂的制备
1-1:散剂的制备
本发明所述的虎掌菇提取物2g
乳糖1g
将上述成分混合后装入密封袋制成散剂。
1-2:片剂的制备
本发明所述的虎掌菇提取物 100mg
玉米淀粉 100mg
乳糖 100mg
硬脂酸镁 2mg
将上述成分混合后,利用常规制备片剂的方法压片制成片剂。
1-3:胶囊剂的制备
本发明所述的虎掌菇提取物100mg
玉米淀粉 100mg
乳糖 100mg
硬脂酸镁 2mg
将上述成分混合后,利用制备胶囊剂的常规方法填充至明胶胶囊制成胶囊剂。
1-4:丸的制备
本发明所述的虎掌菇提取物 1g
乳糖 1.5g
甘油 1g
木糖醇 0.5g
将上述成分混合后,利常规的方法制成丸,每个丸为4g。
1-5:颗粒的制备
本发明所述的虎掌菇提取物 150mg
大豆提取物 50mg
葡萄糖 200mg
淀粉 600mg
将上述成分混合后,添加30%的乙醇100mg,在60℃下干燥形成颗粒,而后装入袋中。
1-6:注射剂的制备
本发明所述的虎掌菇提取物500mg
适量的注射用灭菌蒸馏水
适量的pH调节剂
根据制备注射剂的常规方法,按每1安瓿(2ml)包含上述含量的成分来制备。
1-7:液剂的制备
本发明所述的虎掌菇提取物100mg
异构糖 10g
甘露醇 5g
*适量的纯净水
以制备液剂的常规方法将各成分加入纯净水中溶解,再加入适量柠檬香后混合上述成分,再通过加入纯净水调节到100ml,灌入棕色瓶中灭菌后制成液剂。
制剂例2:保健食品的制备
本发明所述的虎掌菇提取物100mg
适量的维生素混合物
醋酸维生素A 70μg
维生素E 1.0mg
维生素B1 0.13mg
维生素B2 0.15mg
维生素B6 0.5mg
维生素B12 0.2μg
维生素C 10mg
生物素10μg
烟酰胺 1.7mg
叶酸 50μg
泛酸钙 0.5mg
适量的无机混合物
硫酸亚铁 1.75mg
氧化锌 0.82mg
碳酸镁 25.3mg
磷酸一钙 15mg
磷酸二钙 55mg
枸橼酸钙 90mg
碳酸钙 100mg
氯化镁 24.8mg
上述维生素和矿物质的混合物的组成比为按适合保健食品成分的优选实施例混合组成的,也可以改变组成比来实施,按照常规的保健食品的制备方法将上述成分混合后,制成颗粒,并可按照常规的方法使用于保健食品组合物的制备中。
Claims (2)
1.虎掌菇提取物作为唯一活性成分在制备用于预防或治疗痛经或月经不调的药剂中的用途,其特征在于,
上述痛经或月经不调为由雌激素不均衡导致的,
为了预防或治疗上述痛经或月经不调,在痛经开始时服用虎掌菇提取物,
上述虎掌菇提取物为虎掌菇子实体的水提取物,
虎掌菇提取物的制备方法包括:
步骤1),放入水后在45-60℃下30分钟进行第一次提取;
步骤2),在90-105℃下10分钟进行第二次提取;
步骤3),过滤步骤2)的提取物;以及
步骤4),对步骤3)中过滤的提取物进行减压浓缩后进行干燥。
2.虎掌菇提取物作为唯一活性成分在制备用于辅助改善痛经或月经不调的保健食品中的用途,其特征在于,
上述痛经或月经不调由雌激素不均衡导致的,
为了改善上述痛经或月经不调,在痛经开始时服用虎掌菇提取物,
上述虎掌菇提取物为虎掌菇子实体的水提取物,
虎掌菇提取物的制备方法包括:
步骤1),放入水后在45-60℃下30分钟进行第一次提取;
步骤2),在90-105℃下10分钟进行第二次提取;
步骤3),过滤步骤2)的提取物;以及
步骤4),对步骤3)中过滤的提取物进行减压浓缩后进行干燥。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211221745.1A CN115518085B (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2017-0037168 | 2017-03-23 | ||
KR1020170037168A KR101847497B1 (ko) | 2017-03-23 | 2017-03-23 | 능이버섯 추출물을 유효성분으로 함유하는 부인과 질환의 예방 또는 치료용 약학적 조성물 |
CN202211221745.1A CN115518085B (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
CN201880019663.4A CN110430887A (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
PCT/KR2018/002529 WO2018174424A1 (ko) | 2017-03-23 | 2018-03-02 | 능이버섯 추출물을 유효성분으로 함유하는 부인과 질환의 예방 또는 치료용 약학적 조성물 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880019663.4A Division CN110430887A (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115518085A CN115518085A (zh) | 2022-12-27 |
CN115518085B true CN115518085B (zh) | 2024-04-02 |
Family
ID=61975077
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211221745.1A Active CN115518085B (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
CN201880019663.4A Pending CN110430887A (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880019663.4A Pending CN110430887A (zh) | 2017-03-23 | 2018-03-02 | 含有虎掌菇提取物作为有效成分的用于预防或治疗妇科疾病的药学组合物 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20200138883A1 (zh) |
EP (1) | EP3603656A4 (zh) |
JP (1) | JP7108325B2 (zh) |
KR (1) | KR101847497B1 (zh) |
CN (2) | CN115518085B (zh) |
WO (1) | WO2018174424A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101901170B1 (ko) | 2017-06-08 | 2018-09-27 | 우혜진 | 능이버섯 추출물을 유효성분으로 함유하는 월경전 증후군의 예방 또는 치료용 약학적 조성물 |
CN112138126A (zh) * | 2020-08-31 | 2020-12-29 | 广州泽力医药科技有限公司 | 一种有效缓解痛经的组合物及其制备方法 |
US20230202978A1 (en) | 2022-03-04 | 2023-06-29 | Reset Pharmaceuticals, Inc. | Co-crystal or salt |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000355547A (ja) * | 1999-06-11 | 2000-12-26 | Masayuki Maeda | コウタケの成分による治療剤 |
KR20150089188A (ko) * | 2014-01-27 | 2015-08-05 | 대구가톨릭대학교산학협력단 | 능이버섯 추출물을 유효성분으로 포함하는 아토피 피부염 질환의 예방 또는 치료용 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005073502A (ja) | 2003-08-29 | 2005-03-24 | National Food Research Institute | アポトーシス誘導能を有する食品又は食品素材 |
KR102262306B1 (ko) | 2013-07-04 | 2021-06-09 | (주)아모레퍼시픽 | 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물 |
CN103535688A (zh) * | 2013-10-20 | 2014-01-29 | 张路 | 一种虎掌菌酱油的加工方法 |
KR101598283B1 (ko) | 2014-06-30 | 2016-02-29 | 이화여자대학교 산학협력단 | 안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물 |
KR20160058270A (ko) * | 2014-11-14 | 2016-05-25 | 허태호 | 능이버섯, 송이버섯, 호박을 함유하는 항암과 항산화 활성을 가지는 약선죽 및 그의 제조방법 |
KR20160108771A (ko) * | 2015-03-06 | 2016-09-20 | 한국식품연구원 | 능이버섯 추출물을 포함하는 간 질환의 예방 또는 치료용 조성물 |
CN106333159A (zh) | 2015-07-14 | 2017-01-18 | 哈尔滨浩拓生物科技开发有限公司 | 一种山茱萸补益肝肾黑虎掌菌杂菌汤料及其制备方法 |
CN106333163A (zh) * | 2015-07-14 | 2017-01-18 | 哈尔滨浩拓生物科技开发有限公司 | 一种槐角清热泻火黑虎掌菌杂菌汤料及其制备方法 |
KR101771692B1 (ko) * | 2015-09-03 | 2017-08-29 | 호서대학교 산학협력단 | 꽃송이버섯 및 유산균을 유효성분으로 포함하는 갱년기 또는 폐경기 증상의 예방, 치료 또는 개선용 조성물 |
-
2017
- 2017-03-23 KR KR1020170037168A patent/KR101847497B1/ko active IP Right Grant
-
2018
- 2018-03-02 JP JP2020501105A patent/JP7108325B2/ja active Active
- 2018-03-02 CN CN202211221745.1A patent/CN115518085B/zh active Active
- 2018-03-02 CN CN201880019663.4A patent/CN110430887A/zh active Pending
- 2018-03-02 WO PCT/KR2018/002529 patent/WO2018174424A1/ko unknown
- 2018-03-02 US US16/496,159 patent/US20200138883A1/en not_active Abandoned
- 2018-03-02 EP EP18770993.6A patent/EP3603656A4/en not_active Withdrawn
-
2022
- 2022-10-11 US US17/963,888 patent/US11857586B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000355547A (ja) * | 1999-06-11 | 2000-12-26 | Masayuki Maeda | コウタケの成分による治療剤 |
KR20150089188A (ko) * | 2014-01-27 | 2015-08-05 | 대구가톨릭대학교산학협력단 | 능이버섯 추출물을 유효성분으로 포함하는 아토피 피부염 질환의 예방 또는 치료용 조성물 |
Non-Patent Citations (1)
Title |
---|
浅谈月经不调的诊断及治疗;郝晶杰;;中国现代药物应用(第22期);95-96 * |
Also Published As
Publication number | Publication date |
---|---|
EP3603656A4 (en) | 2020-11-11 |
WO2018174424A1 (ko) | 2018-09-27 |
US20230050522A1 (en) | 2023-02-16 |
KR101847497B1 (ko) | 2018-04-10 |
US11857586B2 (en) | 2024-01-02 |
EP3603656A1 (en) | 2020-02-05 |
CN110430887A (zh) | 2019-11-08 |
CN115518085A (zh) | 2022-12-27 |
JP2020511546A (ja) | 2020-04-16 |
JP7108325B2 (ja) | 2022-07-28 |
US20200138883A1 (en) | 2020-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11857586B2 (en) | Pharmaceutical composition for preventing or treating gynecological diseases containing Sarcodon aspratus extracts as active ingredient | |
KR101883065B1 (ko) | 천연 추출물을 포함하는 전립선비대증 예방 또는 치료용 조성물 | |
KR101005972B1 (ko) | 피부외용 조성물 및 그 제조방법 | |
JP2003040787A (ja) | 生理活性を有する組成物およびその製造方法 | |
KR102204346B1 (ko) | 갱년기 증상 또는 골다공증 개선용 조성물 | |
CN102861148B (zh) | 一种治疗原发性痛经的中药制剂及制备方法与应用 | |
KR20170027914A (ko) | 황칠 추출물 또는 황칠액 발효대사체를 포함하는 통풍 예방 또는 치료용 조성물 | |
CN102218127B (zh) | 治疗痛经的中药组合物及其制备方法 | |
KR20150051845A (ko) | 오미자 추출물을 포함하는 갱년기 증후군 개선용 조성물 및 이를 이용한 건강기능식품 | |
JP2018506524A (ja) | バーンアウト症候群の予防、改善、または治療用組成物 | |
KR101732483B1 (ko) | 연교 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물 | |
KR101808944B1 (ko) | 생강 추출물의 비극성 용매 분획물을 유효성분으로 포함하는 월경통 및 조기분만진통의 예방 및 치료용 약학적 조성물 | |
KR101213054B1 (ko) | 국화 및 주증대황의 혼합 추출물을 유효성분으로 함유하는 아토피 예방 및 치료용 조성물 | |
KR102343245B1 (ko) | 감국 지용성 분획 추출물을 유효성분으로 포함하는 아토피의 예방, 개선 또는 치료용 조성물 | |
US10806766B2 (en) | Method for treating, preventing, or alleviating osteoporosis | |
US20220054570A1 (en) | Composition comprising elecampane extract for alleviating premenstrual syndrome symptom | |
KR20120057160A (ko) | 자라 추출물을 함유하는 피부질환의 개선 또는 치료용 약학적 조성물 | |
JP2022546536A (ja) | チョウセンノギク抽出物を含む月経前症候群症状改善用組成物 | |
KR101901170B1 (ko) | 능이버섯 추출물을 유효성분으로 함유하는 월경전 증후군의 예방 또는 치료용 약학적 조성물 | |
CN113181205B (zh) | 包括nmn的药物组合物及其应用 | |
KR101930039B1 (ko) | 인유두종 바이러스 감염에 의한 피부질환의 치료용 조성물 | |
EP3449736B1 (en) | Composition for relieving menopausal symptom or osteoporosis | |
KR20170015142A (ko) | 탈모의 예방, 치료, 또는 육모용 약학조성물 및 그 제조방법 | |
CN112386632A (zh) | 一种治疗原发性痛经的组合物及其制备方法 | |
CN117243991A (zh) | 桂花或其提取物在制备预防和/或治疗脑缺血损伤的药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |